XSTOBONZUN
Market cap392kUSD
Dec 20, Last price
0.01SEK
1D
2.78%
1Q
-55.42%
Jan 2017
-100.00%
IPO
-100.00%
Name
Bonzun AB (publ )
Chart & Performance
Profile
Bonzun AB (publ) operates as a healthcare company that provides Internet-based health services in Sweden. The company offers solutions for stress-related disorders. It also provides support services to the therapists who work with stress, cardiovascular disease, anxiety, relationship problems, etc. The company was formerly known as Papilly AB (publ) and changed its name to Bonzun AB (publ). Bonzun AB (publ) is based in Stockholm, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑09 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 2,736 151.24% | 1,089 202.94% | 359 -35.22% | |||||||
Cost of revenue | 27,991 | 7,852 | 14,693 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (25,255) | (6,763) | (14,333) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (55,226) | 4,864 | 717 | |||||||
Tax Rate | ||||||||||
NOPAT | 29,971 | (11,627) | (15,050) | |||||||
Net income | 13,884 -132.01% | (43,375) 321.43% | (10,292) -0.75% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 21,822 | 9,078 | ||||||||
BB yield | -249.76% | -67.86% | ||||||||
Debt | ||||||||||
Debt current | (298) | |||||||||
Long-term debt | 554 | 667 | 867 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | (22,985) | 298 | (40) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (25,113) | (7,725) | (7,320) | |||||||
CAPEX | (651) | (1,592) | (1,925) | |||||||
Cash from investing activities | 3,013 | (1,592) | (1,925) | |||||||
Cash from financing activities | 21,934 | 9,078 | 9,672 | |||||||
FCF | 17,323 | (10,264) | (389) | |||||||
Balance | ||||||||||
Cash | 203 | 369 | 609 | |||||||
Long term investments | 23,336 | |||||||||
Excess cash | 23,402 | 315 | 591 | |||||||
Stockholders' equity | (126,357) | (61,316) | 8,455 | |||||||
Invested Capital | 166,713 | 72,165 | 29,554 | |||||||
ROIC | 25.09% | |||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 124,461 | 34,388 | 575,760 | |||||||
Price | 0.07 -81.95% | 0.39 -71.19% | 1.35 -70.65% | |||||||
Market cap | 8,737 -34.69% | 13,377 -98.28% | 777,277 2,734.09% | |||||||
EV | (14,248) | 13,675 | 798,035 | |||||||
EBITDA | (19,027) | (6,763) | (11,850) | |||||||
EV/EBITDA | 0.75 | |||||||||
Interest | 6,530 | 2,404 | 717 | |||||||
Interest/NOPBT |